)
)
)
Precision Lifesciences Group
Precision Lifesciences Group, based in Nashville, Tennessee, is developing immune-based therapies for the treatment of cancer. Precision Lifesciences Group is seeking partners for its clinical-stage programs - ICT-107, ICT-121 and ICT-140 - which are patient-specific, dendritic cell-based immunotherapies targeting solid tumors.
Precision Life Sciences Group’s product candidates stimulate a powerful immune response that can destroy cancer cells and prevent tumor recurrence. These cancer immunotherapeutics activate the body’s immune system against tumor-associated antigens, which are overexpressed on cancer stem cells and other cancer cells. In mounting an effective immune response, the body recruits immune cells, such as T cells, to destroy the cancer and prevent its recurrence. This approach to activating the immune response offers the promise of improved survival through treatments that are potentially safer and more effective than conventional cancer therapies.
Address
NashvilleTennessee
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)